“Decreases in hospital-onset MRSA [bloodstream infections] may be due to substantial efforts aimed to reduce healthcare-associated infection,” Kyle J. Popovich, MD, assistant professor at Rush University Medical Center in Chicago and lead author of the study, said in a statement. “Enhanced prevention efforts in the community for certain populations, such as those engaging in illicit drug use, may be necessary to further curb the spread of invasive MRSA infections.”
The USA 300 strain is responsible for more than half of hospital-acquired MRSA infection over the past 15, according to the study.
More articles on infection control:
Experimental bandage shown to pull staph bacteria from wounds
Health professionals have mixed reaction to GOP’s debate on vaccines, autism
‘We know what to do with sepsis’: Ohio hospitals renew sepsis mortality reduction efforts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
